AMARIN CORP PLC\UK Senior Notes, Noncurrent
AMARIN CORP PLC\UK (AMRN) had Senior Notes, Noncurrent of $29.16 million as of 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities
us-gaap:SeniorLongTermNotes · last filed 2019-02-27
- 2018-09-30: Senior Notes, Noncurrent $29.16M.
- 2018-06-30: Senior Notes, Noncurrent $29.10M.
- 2018-03-31: Senior Notes, Noncurrent $29.05M.
- 2017-12-31: Senior Notes, Noncurrent $28.99M.
| Period end | Senior Notes, Noncurrent | Senior Notes, Noncurrent as first filed |
|---|---|---|
| 2018-09-30 | $29.16M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $29.10M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $29.05M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $28.99M 10-K · filed 2019-02-27 | |
| 2017-09-30 | $28.94M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $28.88M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $28.83M 10-Q · filed 2017-05-03 | |
| 2016-06-30 | $125.64M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $138.70M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $136.73M 10-K · filed 2017-03-01 | $138.60M 10-K · filed 2016-02-25 |
| 2015-09-30 | $126.11M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $124.63M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $123.19M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $121.85M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $120.49M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $119.17M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $150.00M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $149.32M 10-K · filed 2015-03-03 | |
| 2013-09-30 | $145.32M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $141.46M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $137.74M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $134.25M 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |